Valero V - Search Results

1

Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.

Buchholz TA, Hill BS, Tucker SL, Frye DK, Kuerer HM, Buzdar AU, McNeese MD, Singletary SE, Ueno NT, Pusztai L, Valero V, Hortobagyi GN. Buchholz TA, et al. Among authors: valero v. Cancer J. 2001 Sep-Oct;7(5):413-20. Cancer J. 2001. PMID: 11693900

2

Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.

Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK. Chagpar A, et al. Among authors: valero v. Cancer. 2005 Apr 15;103(8):1581-6. doi: 10.1002/cncr.20934. Cancer. 2005. PMID: 15747375 Free article. Review.

3

Clinical course of breast cancer patients with metastases confined to the lungs treated with chemotherapy. The University of Texas M.D. Anderson Cancer Center experience and review of the literature.

Diaz-Canton EA, Valero V, Rahman Z, Rodriguez-Monge E, Frye D, Smith T, Buzdar AU, Hortobagyi GN. Diaz-Canton EA, et al. Among authors: valero v. Ann Oncol. 1998 Apr;9(4):413-8. doi: 10.1023/a:1008205522875. Ann Oncol. 1998. PMID: 9636832 Free article.

4

Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.

Pusztai L, Walters RS, Valero V, Theriault RL, Hortobagyi GN. Pusztai L, et al. Among authors: valero v. Am J Clin Oncol. 1998 Oct;21(5):442-6. doi: 10.1097/00000421-199810000-00004. Am J Clin Oncol. 1998. PMID: 9781596 Clinical Trial.

5

Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.

Holmes FA, Valero V, Walters RS, Theriault RL, Booser DJ, Gibbs H, Fraschini G, Buzdar AU, Willey J, Frye D, Asmar L, Hortobagyi GN. Holmes FA, et al. Among authors: valero v. Ann Oncol. 1999 Apr;10(4):403-11. doi: 10.1023/a:1008360406322. Ann Oncol. 1999. PMID: 10370782 Free article. Clinical Trial.

6

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

Ibrahim NK, Rahman Z, Valero V, Willey J, Theriault RL, Buzdar AU, Murray JL 3rd, Bast R, Hortobagyi GN. Ibrahim NK, et al. Among authors: valero v. Cancer. 1999 Oct 1;86(7):1251-7. doi: 10.1002/(sici)1097-0142(19991001)86:7<1251::aid-cncr21>3.0.co;2-f. Cancer. 1999. PMID: 10506711 Clinical Trial.

7

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GN. Buzdar AU, et al. Among authors: valero v. J Clin Oncol. 1999 Nov;17(11):3412-7. doi: 10.1200/JCO.1999.17.11.3412. J Clin Oncol. 1999. PMID: 10550135 Clinical Trial.

8

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

Hortobagyi GN, Buzdar AU, Theriault RL, Valero V, Frye D, Booser DJ, Holmes FA, Giralt S, Khouri I, Andersson B, Gajewski JL, Rondon G, Smith TL, Singletary SE, Ames FC, Sneige N, Strom EA, McNeese MD, Deisseroth AB, Champlin RE. Hortobagyi GN, et al. Among authors: valero v. J Natl Cancer Inst. 2000 Feb 2;92(3):225-33. doi: 10.1093/jnci/92.3.225. J Natl Cancer Inst. 2000. PMID: 10655439 Clinical Trial.

9

Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer.

Ibrahim NK, Sahin AA, Dubrow RA, Lynch PM, Boehnke-Michaud L, Valero V, Buzdar AU, Hortobagyi GN. Ibrahim NK, et al. Among authors: valero v. Lancet. 2000 Jan 22;355(9200):281-3. doi: 10.1016/S0140-6736(99)06195-4. Lancet. 2000. PMID: 10675076 Clinical Trial.

10

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy.

Hoff PM, Valero V, Buzdar AU, Singletary SE, Theriault RL, Booser D, Asmar L, Frye D, McNeese MD, Hortobagyi GN. Hoff PM, et al. Among authors: valero v. Cancer. 2000 May 1;88(9):2054-60. doi: 10.1002/(sici)1097-0142(20000501)88:9<2054::aid-cncr11>3.0.co;2-j. Cancer. 2000. PMID: 10813717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

486 results

Search Page